Home Cart Sign in  
Chemical Structure| 572-31-6 Chemical Structure| 572-31-6

Structure of Engeletin
CAS No.: 572-31-6

Chemical Structure| 572-31-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Engeletin, derived from Smilax glabra Roxb., inhibits the activation of the NF-κB signaling pathway and possesses anti-inflammatory, analgesic, diuretic, anti-edema, and antibacterial effects.

Synonyms: Dihydrokaempferol 3-O-α-L-rhamnopyranoside; Dihydrokaempferol 3-rhamnoside; (2R,3R)-Engelitin, Dihydrokaempferol 3-O-α-L-rhamnopyranoside, Dihydrokaempferol 3-rhamnoside, Engelitin

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Engeletin

CAS No. :572-31-6
Formula : C21H22O10
M.W : 434.39
SMILES Code : O=C1[C@H](O[C@H]2[C@@H]([C@@H]([C@H]([C@H](C)O2)O)O)O)[C@@H](C3=CC=C(O)C=C3)OC4=CC(O)=CC(O)=C14
Synonyms :
Dihydrokaempferol 3-O-α-L-rhamnopyranoside; Dihydrokaempferol 3-rhamnoside; (2R,3R)-Engelitin, Dihydrokaempferol 3-O-α-L-rhamnopyranoside, Dihydrokaempferol 3-rhamnoside, Engelitin
MDL No. :MFCD11113110
InChI Key :VQUPQWGKORWZII-WDPYGAQVSA-N
Pubchem ID :6453452

Safety of Engeletin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Engeletin

pyroptosis

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
RAW264.7 cells 5, 10, 20, 40 μM 5 days CU-CPT22 significantly inhibited Pam3CSK4-induced TRL2/1 signaling PMC10225148
NCI-N87 cells 5 μM 24 hours Engeletin alleviated CDO1-induced oxidative stress and integrated stress response (ISR), restoring the proliferation ability of GC cells. PMC9758200
MKN45 cells 5 μM 24 hours To evaluate the effect of IDF-11774 on HIF-1α expression, results showed that IDF-11774 significantly reduced HIF-1α expression PMC9758200
Rat nucleus pulposus cells 80 µM 24 hours To evaluate the anti-inflammatory effects of Engeletin on TNF-α-induced inflammation. Results showed that Engeletin effectively inhibited the up-regulation of inflammatory mediators (iNOS, IL-1β, IL-6, COX2, and TNF-α) at both mRNA and protein levels. PMC9553281
Rat chondrocytes 10 μM and 20 μM 24 hours Engeletin pretreatment alleviated TNF-α-induced inhibition of ECM components (collagen II and aggrecan) and upregulation of matrix catabolic enzymes (MMP9 and MMP3). PMC7955871

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Sprague Dawley rats Transient middle cerebral artery occlusion (tMCAO) model Intravenous injection 15, 30, 60 mg/kg Immediately administered, lasting for 22.5 hours To evaluate the neuroprotective effects of Engeletin on cerebral ischemia-reperfusion injury, results showed that Engeletin significantly reduced neurological deficit scores, infarct volume, brain edema, and levels of inflammatory factors. PMC10273068
C57BL/6 mice Chronic restraint stress (CRS) model Intragastric administration 2.5, 5, 10, 20 mg/kg Once daily for 28 days To evaluate the antidepressant effects of Engeletin in the CRS model, results showed that Engeletin significantly reduced immobility time in FST and TST, and reversed CRS-induced weight loss and reduced sucrose preference. PMC10718134
Sprague-Dawley rats Percutaneous needle puncture-induced intervertebral disc degeneration model Intradiscal injection 80 µM Once a week for 4 weeks To evaluate the therapeutic effects of Engeletin on intervertebral disc degeneration in vivo. Results showed that Engeletin partially maintained disc height and T2WI signal intensity, inhibited the expression of inflammatory mediators and matrix-degrading enzymes, and alleviated nucleus pulposus cell apoptosis. PMC9553281
C57BL/6J mice Ovariectomy-induced osteoporosis model Intraperitoneal injection 5 mg/kg Every other day for 8 weeks To assess the protective effect of Engeletin on bone loss in ovariectomized mice. Results demonstrated that Engeletin significantly reduced bone loss induced by ovariectomy and increased trabecular number and thickness. PMC10225148
C57BL/6J mice Chronic social defeat stress (CSDS) model Intragastric administration 5, 10, 20 mg/kg Once daily for 21 days Engeletin significantly alleviated depressive-like behaviours in CSDS model mice by modulating the LCN2/CXCL10 signalling pathway and altering microglial polarization. PMC11005460
Sprague-Dawley rats ACLT-induced osteoarthritis model Intraarticular injection 50 μg per injection Once a week for 4 or 8 weeks Engeletin alleviated ACLT-induced knee OA in rats via intraarticular injection. PMC7955871

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.30mL

0.46mL

0.23mL

11.51mL

2.30mL

1.15mL

23.02mL

4.60mL

2.30mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories